Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients

NCT00196287 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2018-03-12

No results posted yet for this study

Summary

The purpose of this study was to investigate differences in risk prediction in female post-infarction patients.

Conditions

Sponsors & Collaborators

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Principal Investigators

  • Georg Schmidt, MD · Deutsches Herzzentrum Muenchen

  • Petra Barthel, MD · Deutsches Herzzentrum Muenchen

  • Axel Bauer, MD · Deutsches Herzzentrum Muenchen

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00196287 on ClinicalTrials.gov